Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adeno-carcinoma A549/DDP cell to cisplatin and diallyl disulfide

Acta Biochimica et Biophysica Sinica

Volumn 39, Issue 11, 2007, Pages 835-843

  Huang, Zexiang ^a   Lei, Xiaoyong ^a   Zhong, Miao ^a   Zhu, Bingyang ^a   Tang, Shengsong ^a   Liao, Duanfang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

A549 DDP; Adenocarcinoma; Apoptosis; Bcl 2; Small interfering RNA

Indexed keywords

ALLYL COMPOUND; ANTINEOPLASTIC AGENT; CISPLATIN; DIALLYL DISULFIDE; DISULFIDE; PROTEIN BCL 2; SMALL INTERFERING RNA;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; DRUG RESISTANCE; GENE SILENCING; GENE THERAPY; GENETICS; HUMAN; LUNG TUMOR; METHODOLOGY; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ALLYL COMPOUNDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; DISULFIDES; DRUG RESISTANCE, NEOPLASM; GENE SILENCING; GENE THERAPY; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING;

EID: 36248993363     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2007.00356.x     Document Type: Article

References (26)

1. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000 355 479 485.
2. Sundaram SG, Milner JA. Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis 1996 17 669 673.
3. Hong YS, Ham YA, Choi JH, Kim J. Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp Mol Med 2000 32 127 134.
4. Kwon KB, Yoo SJ, Ryu DG, Yang JY, Rho HW, Kim JS. Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem Pharmacol 2002 63 41 47.
5. Nakagawa H, Tsuta K, Kiuchi K, Senzaki H, Tanaka K, Hioki K. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 2001 22 891 897.
6. Nishio K, Nakamura T, Koh Y, Suzuki T, Fukumoto H, Saijo N. Drug resistance in lung cancer. Curr Opin Oncol 1999 11 109 115.
7. Kim EH, Kim SU, Shin DY, Choi KS. Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP. Oncogene 2004 23 446 456.
8. Adams JM, Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science 1998 281 1322 1326.
9. Yang X, Zheng F, Xing H, Gao Q, Wei W, Lu Y, Wang S et al. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. J Cancer Res Clin Oncol 2004 130 423 428.
10. Perego P, Righetti SC, Supino R, Delia D, Caserini C, Carenini N, Bedogne B et al. Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines. Apoptosis 1997 2 540 548.
11. Zhang YL, Yue JR, Dong BR. Abnormal expression of caspase8, bcl-2 and cytochrome C in drug resistant lung cancer cell. Sichuan Da Xue Xue Bao Yi Xue Ban 2005 36 786 788.
12. Yu L, Wang Z. Difference in expression of Bcl-2 and Bcl-xl genes in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. J Huazhong Univ Sci Technology Med Sci 2004 24 151 153.
13. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteolysis. Cell 1997 91 443 446.
14. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998 281 1309 1312.
15. Hannon GJ. RNA interference. Nature 2002 418 244 251.
16. Shoemaker AR, Oleksijew A, Bauch J, Belli BA, Borre T, Bruncko M, Deckwirth T et al. A small-molecule inhibitor of Bcl-xl potentiates the activity of cytotoxic drugs in vitro and in vivo. Cancer Res 2006 66 8731 8739.
17. Zangemeister-Wittke U, Leech SH, Olie RA, Simoes-Wust AP, Gautschi O, Luedke GH, Natt F et al. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xl expression efficiently induces apoptosis in tumor cells. Clin Cancer Res 2000 6 2547 2555.
18. Huang SL, Wu Y, Yu H, Zhang P, Zhang XQ, Ying L, Zhao HF. Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells. Acta Pharmacol Sin 2006 27 242 248.
19. Fu GF, Lin XH, Han QW, Fan YR, Xu YF, Guo D, Xu GX et al. RNA interference remarkably suppresses bcl-2 gene expression in cancer cells in vitro and in vivo. Cancer Biol Ther 2005 4 822 829.
20. Feng LF, Zhong M, Lei XY, Zhu BY, Tang SS, Liao DF. Bcl-2 siRNA induced apoptosis and increased sensitivity to 5-fluorouracil and HCPT in HepG2 cells. J Drug Target 2006 14 21 26.
21. Lei XY, Zhong M, Feng LF, Zhu BY, Tang SS, Liao DF. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemo-therapeutic drugs. Clin Exp Pharmacol Physiol 2007 34 450 456.
22. Lei XY, Zhong M, Feng LF, Zhu BY, Tang SS, Liao DF. Bcl-xl small interfering RNA enhances sensitivity of Hepg2 hepatocellular carcinoma cells to 5-fluorouracil and gydroxycamptothecin. Acta Biochim Biophys Sin 2006 38 704 710.
23. Yin ZH, Ren CP, Li F, Yang XY, Li H, Zhao M, Yao KT. Suppression of bcl-2 gene by RNA interference increases chemosensitivity to cisplatin in nasopharyngeal carcinoma cell line CNE1. Acta Biochim Biophys Sin 2004 36 749 753.
24. Fjose A, Ellingsen S, Wargelius A, Seo HC. RNA interference: Mechanisms and applications. Biotechnol Annu Rev 2001 7 31 57.
25. Brummelkamp HR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002 296 550 553.
26. Wall NR, Shi Y. Small RNA: Can RNA interference be exploited for therapy? Lancet 2003 362 1401 1403.